Hugel, a local botulinum toxin (Botox or BTX) maker, is facing a setback in its attempt to enter the Botox market in the United States as the U.S. Food and Drug Administration (FDA) rejected the documents and data to license the BTX for use, according to industry officials Wednesday.
SITE Centers Corp. (NYSE:SITC – Get Rating) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 8,200,000 shares, a drop of 28.4% from the March 15th total of 11,450,000 shares. Based on an average daily volume of 1,890,000 shares, the days-to-cover ratio is presently 4.3 days. […]
SITE Centers (NYSE:SITC – Get Rating) and Franklin BSP Realty Trust (NYSE:FBRT – Get Rating) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Earnings & Valuation This table compares SITE Centers […]
The tech giants faced criticism from a California judge over ‘expert reports’ | Smart speaker manufacturer accuses Google of ‘flooding the market’ with infringing products.
SITE Centers Corp. (NYSE:SITC – Get Rating) – Stock analysts at Jefferies Financial Group reduced their FY2023 earnings estimates for SITE Centers in a research note issued to investors on Thursday, March 23rd. Jefferies Financial Group analyst L. Tsai now expects that the company will earn $1.13 per share for the year, down from their […]